medigraphic.com
Instituto Nacional de Salud Pública

2020, Number 1

<< Back Next >>

salud publica mex 2020; 62 (1)

Prevalence of diabetes and poor glycemic control in Mexico: results from Ensanut 2016

Basto-Abreu A, Barrientos-Gutiérrez T, Rojas-Martínez R, Aguilar-Salinas CA, López-Olmedo N, De la Cruz-Góngora V, Rivera-Dommarco J, Shamah-Levy T, Romero-Martínez M, Barquera S, López-Ridaura R, Hernández-Ávila M, Villalpando S

Language: Spanish
References: 30
Page: 50-59
PDF size: 293.18 Kb.


ABSTRACT

Objective. To estimate the prevalence of total, diagnosed and undiagnosed diabetes, and the prevalence of poor glycemic control in Mexico, and its associated factors. Materials and methods. Data from 3 700 adult participants were analysed in the 2016 National Health and Nutrition Survey. Diabetes prevalences were estimated with population weights, and the factors associated with total diabetes and poor glycemic control with Poisson regression models. Results The total prevalence of diabetes was 13.7% (9.5% diagnosed, 4.1% undiagnosed); 68.2% of people with diagnosed diabetes presented poor glycemic control. Longer disease duration, living in the centre or south of the country and being treated in pharmacies were associated with poor glycemic control. Being treated in a social security system was associated with better glycemic control. Conclusion. Multisectoral efforts are needed to strengthen screening, timely diagnosis and disease control, considering differences by region and type of health service.


REFERENCES

  1. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137-49. https://doi. org/10.1016/j.diabres.2013.11.002

  2. Institute for Health Metrics and Evaluation. GBD Compare 2016. Washington: University of Washington, 2017 [citado marzo 12, 2017]. Disponible en: http://ihmeuw.org/3pgz

  3. Instituto Nacional de Estadística y Geografía. Comunicado de prensa núm 525/18 [Internet]. Ciudad de Mexico: INEGI, 2018 [citado abril 26, 2019]. Disponible en: http://www.beta.inegi.org.mx/contenidos/saladeprensa/ boletines/2018/EstSociodemo/DEFUNCIONES2017.pdf

  4. Arredondo A, Reyes G. Health disparities from economic burden of diabetes in middle-income countries: Evidence from México. PLoS One. 2013;8(7):e68443. https://doi.org/10.1371/journal.pone.0068443

  5. Secretaría de la Salud. Emite la Secretaría de Salud emergencia epidemiológica por diabetes mellitus y obesidad [internet]. Ciudad de México: Secretaría de Salud, 2016 [citado febrero 2, 2018]. Disponible en: https:// www.gob.mx/salud/prensa/emite-la-secretaria-de-salud-emergencia-epidemiologica- por-diabetes-mellitus-y-obesidad

  6. Villalpando S, de la Cruz V, Rojas R, Shamah-Levy T, Avila MA, Gaona B, et al. Prevalence and distribution of type 2 diabetes mellitus in Mexican adult population: A probabilistic survey. Salud Publica Mex. 2010;52(suppl 1): S19-26. https://doi.org/10.1590/S0036-36342010000700005

  7. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(suppl 1): S81-90. https://doi.org/10.2337/ dc14-S081

  8. Secretaría de Salud. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016 (Ensanut MC 2016) [internet]. Cuernavaca: INSP, 2016 [citado enero 21, 2019]. Disponible en: https://www.gob.mx/cms/uploads/ attachment/file/209093/ENSANUT.pdf

  9. Fundación Mídete. Asumiendo el control de la diabetes. México 2016. México: Fundación Mídete, 2016 [citado abril 26, 2019]. Disponible en: http://oment.salud.gob.mx/wp-content/uploads/2016/11/FMidete_Asumiendo- Control-Diabetes-2016.pdf

  10. Kanavos P, Van Den Aardweg S, Schurer W. Diabetes expenditure, burden of disease and management in 5 EU countries. Inglaterra: London School of Economics, 2012 [citado abril 13, 2019]. Disponible en: http:// www.lse.ac.uk/business-and-consultancy/consulting/assets/documents/ diabetes-expenditure-burden-of-disease-and-management-in-5-eucountries. pdf

  11. Bello-Chavolla OY, Rojas-Martinez R, Aguilar-Salinas CA, Hernández- Avila M. Epidemiology of diabetes mellitus in Mexico. Nutr Rev. 2017;75(suppl 1): 4-12. https://doi.org/10.1093/nutrit/nuw030

  12. Romero-Martínez M, Shamah-Levy T, Cuevas-Nasu L, Méndez Gómez- Humarán I, Gaona-Pineda EB, Gómez-Acosta LM, et al. Diseño metodológico de la Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Salud Publica Mex. 2017;59(3):299-205. https://doi.org/10.21149/8593

  13. Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015;314(10):1021-9. https://doi.org/10.1001/jama.2015.10029

  14. Zhang N, Yang X, Zhu X, Zhao B, Huang T, Ji Q. Type 2 diabetes mellitus unawareness, prevalence, trends and risk factors: National Health and Nutrition Examination Survey (NHANES) 1999-2010. J Int Med Res. 2017;45(2):594-609. https://doi.org/10.1177/0300060517693178

  15. American Diabetes Association. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(suppl 1):S13-28. https://doi.org/10.2337/dc19-S002

  16. Secretaría de Salud. Norma Oficial Mexicana NOM-015-SSA2-2010, Para la prevención, tratamiento y control de la diabetes mellitus [internet]. Ciudad de México: Diario Oficial de la Federación, 2009 [citado abril 26, 2019]. Disponible en: http://www.dof.gob.mx/normasOficiales/4215/ salud/salud.htm

  17. Basto-Abreu A, Barrientos-Gutierrez T, Rojas-Martínez R, Aguilar-Salinas CA, López-Olmedo N, de la Cruz-Góngora V, et al. Apéndice al artículo “Prevalencia de diabetes y descontrol glucémico en México: resultados de ENSANUT 2016”. Fighsare [internet]. 2019 [citado abril 13,2019]. Disponible en: https://figshare.com/articles/Supplementary_file/9902648/2

  18. World Health Organization. Obesity and overweight [internet]. Ginebra: WHO, 2018 [citado septiembre 22, 2018]. Disponible en: https://www. who.int/news-room/fact-sheets/detail/obesity-and-overweight

  19. Rojas-Martínez R, Escamilla-Núñez C, Gómez-Velasco DV, Zárate- Rojas E, Aguilar-Salinas CA. Diseño y validación de un score para detectar adultos con prediabetes y diabetes no diagnosticada. Salud Publica Mex. 2018;60(5):500-509. https://doi.org/10.21149/9057

  20. Dwivedi AK, Mallawaarachchi I, Lee S, Tarwater P. Methods for estimating relative risk in studies of common binary outcomes. J Appl Stat. 2014;41(3):484-500. https://doi.org/10.1080/02664763.2013.840772

  21. Secretaría de Salud. Programa de acción específico. Prevención y control de la diabetes mellitus 2013-2018. Ciudad de Mexico: Secretaría de Salud, 2014 [citado abril 13, 2019]. Disponible en: http://www.cenaprece. salud.gob.mx/descargas/pdf/PAE_PrevencionControlDiabetesMellitus2013_ 2018.pdf

  22. Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes Res Clin Pract. 2014;103(2):150-60. https://doi.org/10.1016/j.diabres.2013.11.001

  23. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Estimates of Diabetes and Its Burden in the United States [internet]. Atlanta: CDC, 2017 [citado mayo 30, 2018]. Disponible en: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetesstatistics- report.pdf

  24. Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med. 2014;160(8):517-25. https://doi.org/10.7326/M13-2411

  25. Rojas-Martínez R, Basto-Abreu A, Aguilar-Salinas CA, Zárate-Rojas E, Villalpando S, Barrientos-Gutiérrez T. Prevalencia de diabetes por diagnóstico médico previo en México. Salud Publica Mex. 2018;60(3):224-32. https://doi.org/10.21149/8566

  26. Flores-Hernández S, Saturno-Hernández PJ, Reyes-Morales H, Barrientos- Gutiérrez T, Villalpando S, Hernández-Ávila M. Quality of diabetes care: The challenges of an increasing epidemic in Mexico. Results from two national health surveys (2006 and 2012). PLoS One. 2015;10(7):e0133958. https://doi.org/10.1371/journal.pone.0133958

  27. Al Mansari A, Obeid Y, Islam N, Fariduddin M, Hassoun A, Djaballah K, et al. GOAL study: clinical and non-clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice. BMJ Open Diabetes Res care. 2018;6(1):e000519. https://doi.org/10.1136/ bmjdrc-2018-000519

  28. Díaz-Portillo SP, Idrovo AJ, Dreser A, Bonilla FR, Matías-Juan B, Wirtz VJ. Consultorios adyacentes a farmacias privadas en México: infraestructura y características del personal médico y su remuneración. Salud Publica Mex. 2015;57:320-8. https://doi.org/10.21149/spm.v57i4.7575

  29. Centro Nacional de Excelencia Tecnológica en Salud. Diagnóstico y Tratamiento Farmacológico de la Diabetes Mellitus Tipo 2 en el primer nivel de atención. Guía de Evidencia y Recomendaciones: Guía de Práctica Clínica. Ciudad de México: CENETEC, 2018 [citado 2019 abr 29]. Disponible en: http://www.cenetec-difusion.com/CMGPC/GPC-IMSS-718-18/ER.pdf

  30. Barrientos-Gutiérrez T, Colchero MA, Sánchez-Romero LM, Batis C, Rivera-Dommarco J. Posicionamiento sobre los impuestos a alimentos no básicos densamente energéticos y bebidas azucaradas. Salud Publica Mex. 2018;60:586-91. https://doi.org/10.21149/9534




2020     |     www.medigraphic.com